Search Results

Study Evaluates Risk Factors and Reintervention Outcomes of Acute Iliofemoral DVT Intervention; Classification System Developed

September 28, 2022—In a single-center, retrospective cohort study published in Journal of Vascular Surgery: Venous and Lymphatic Disorders, Pouncey et al found that a significant proportion of patients who underwent deep venous stenting for acute iliofemoral deep vein thrombosis (DVT) required reintervention due to potentially preventable factors.

Feasibility Cohort Presented for VIRTUS Iliofemoral Venous Stenting Study

September 19, 2016—Stephen Black, MD, presented results from the VIRTUS trial during the first Late-Breaking Trials session at VIVA 16, the 14th annual Vascular InterVentional Advances meeting, which is sponsored by VIVA Physicians, Inc. and held September 18–22, 2016 at the Wynn Las Vegas in Las Vegas, Nevada.

Medtronic’s Abre Venous Self-Expanding Stent System Shows Sustained Effectiveness at 36 Months

October 14, 2022—Medtronic announced that the 36-month, final results from the ABRE clinical study were presented by Professor Stephen Black, MD, in a late-breaking clinical trial session at AVLS 2022, the 36th annual congress of the American Vein and Lymphatic Society held October 13-16 in New Orleans, Louisiana.

Medtronic's ABRE Venous Stent Study Meets Safety and Effectiveness Endpoints; 12-Month Data Presented

June 16, 2020—Twelve-month data from Medtronic's ABRE pivotal, investigational device exemption, venous stent study were presented by Stephen Black, MD, during a Charing Cross (CX) 2020 virtual session dedicated to deep venous disease.

Gore’s Viabahn Fortegra Venous Stent Evaluated in Deep Venous Iliocaval Obstruction

November 7, 2025—Gore & Associates announced trial results evaluating the investigational Viabahn Fortegra venous stent for the treatment of deep venous iliocaval obstruction.

Veniti Completes First Use of CE Mark Approved Vici Verto Venous System

April 21, 2016—Veniti, Inc. announced the initial use of the company’s Vici Verto venous stent system for the successful treatment of a patient with postthrombotic syndrome associated with venous outflow obstruction.

Pain and QoL Data Presented for Gore’s Viabahn Fortegra Venous Stent

April 22, 2026—Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluated treatment of patients with symptomatic deep venous iliocaval obstruction.

Inari Medical Begins DEFIANCE Randomized Clinical Trial of ClotTriever System in DVT

January 12, 2023—Inari Medical, Inc. announced that the first patient has been enrolled in the DEFIANCE prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients with iliofemoral deep vein thrombosis (DVT) treated with the company’s ClotTriever system versus anticoagulation only.

Veniti's Vici Venous Stent System Introduced With First Cases In Europe

January 23, 2014—Veniti, Inc. (St.

Outcomes in Postpartum Women After CDT and Stenting for Iliofemoral DVT

February 20, 2020—The Society for Vascular Surgery (SVS) announced that findings from a single-center review of postpartum women undergoing catheter-directed thrombolysis (CDT) and stenting for acute iliofemoral deep vein thrombosis (DVT) may be more likely to experience stent occlusion and require reintervention.

First-in-Human Study Begins for Vetex Thrombectomy Catheter to Treat DVT

December 18, 2018—Vetex Medical Ltd. announced that the first patient has been treated in the VETEX trial, a first-in-human evaluation of venous thrombus extraction with the company's Vetex thrombectomy catheter.